Showing results (131-140 of 153) with videos related to
Sort By:
Pageof 16
The Journal of Experimental Medicine|May 7, 2014
Immunity induced by a broad class of inorganic crystalline materials is directly controlled by their chemistryGareth R Williams, Kaat Fierens, Stephen G Preston, et al.BMC Genomics|October 6, 2021
Repertoire analysis of γδ T cells in the chicken enables functional annotation of the genomic region revealing highly variable pan-tissue TCR gamma V gene usage as well as identifying public and private repertoiresRobert Dixon, Stephen G Preston, Stefan Dascalu, et al.Plos Pathogens|July 5, 2013
Novel immunomodulators from hard ticks selectively reprogramme human dendritic cell responsesStephen G Preston, Juraj Majtán, Chrisoula Kouremenou, et al.Applied and Environmental Microbiology|September 22, 2021
Parallel Sequencing Reveals Campylobacter spp. in Commercial Meat Chickens Less than 8 Days OldF M Colles, S J Hedges, R Dixon, et al.Frontiers in Immunology|January 23, 2023
The influences of microbial colonisation and germ-free status on the chicken TCRβ repertoireStefan Dascalu, Stephen G Preston, Robert J Dixon, et al.Proceedings. Biological Sciences|October 5, 2018
Molecular archaeoparasitology identifies cultural changes in the Medieval Hanseatic trading centre of LübeckPatrik G Flammer, Simon Dellicour, Stephen G Preston, et al.Genes & Cancer|January 26, 2016
Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndromeAung Ko Win, Mark Clendenning, William Crawford, et al.Cancer Chemotherapy and Pharmacology|September 17, 2008
Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumorsChia-Chi Lin, Emiliano Calvo, Kyriakos P Papadopoulos, et al.Familial Cancer|June 15, 2023
A mosaic pathogenic variant in MSH6 causes MSH6-deficient colorectal and endometrial cancer in a patient classified as suspected Lynch syndrome: a case reportRomy Walker, Mark Clendenning, Jihoon E Joo, et al.Journal of Medicinal Chemistry|July 14, 2021
Optimization of a Series of 2,3-Dihydrobenzofurans as Highly Potent, Second Bromodomain (BD2)-Selective, Bromo and Extra-Terminal Domain (BET) InhibitorsSimon C C Lucas, Stephen J Atkinson, Chun-Wa Chung, et al.Pageof 16